Immunomedics files investigational new drug application with FDA for cancer imaging agents.
D000911:Antibodies, Monoclonal; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging*; D009373:Neoplasms, Germ Cell and Embryonal / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013667:Technetium; D014481:United States; D014486:United States Food and Drug Administration; D000509:alpha-Fetoproteins / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000509:alpha-Fetoproteins; D013667:Technetium